Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Beta blocker use and breast cancer survival by subtypes: A population-based cohort study.

Scott OW. et al, (2025), Breast, 81

Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.

Park SH. et al, (2025), Thyroid

Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study.

Aye PS. et al, (2025), JMIR Cancer, 11

Incidence trends of ductal carcinoma in situ in New Zealand women between 1999 and 2022.

Chen Q. et al, (2025), Breast Cancer Res Treat

Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis.

Chen Q. et al, (2024), Breast Cancer Res Treat

Correction to: Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: which factors contribute?

Boyle L. et al, (2024), Breast Cancer Res Treat

Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy.

Aye PS. et al, (2024), JMIR Res Protoc, 13

Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort.

Matta K. et al, (2024), BMC Med, 22

Associations between transport modes and site-specific cancers: a systematic review and meta-analysis.

Thu W. et al, (2024), Environ Health, 23

Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: which factors contribute?

Boyle L. et al, (2024), Breast Cancer Res Treat

BMI and breast cancer risk around age at menopause.

Von Holle A. et al, (2024), Cancer Epidemiol, 89

Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition.

Botteri E. et al, (2024), Eur J Epidemiol

Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies.

Fontvieille E. et al, (2023), BMC Med, 21

Receipt of mastectomy and adjuvant radiotherapy following breast conserving surgery (BCS) in New Zealand women with BCS-eligible breast cancer, 2010-2015: an observational study focusing on ethnic differences.

Bartholomew K. et al, (2023), BMC Cancer, 23

A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.

Christakoudi S. et al, (2023), BMC Cancer, 23

Incidence, trends, and survival of oropharyngeal squamous cell cancer in Aotearoa New Zealand, 2006-2020.

Win Myint TT. et al, (2023), Cancer Epidemiol, 85

Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study

Scott OW. et al, (2023), Breast Cancer Research and Treatment, 199, 195 - 206

Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition.

Mahamat-Saleh Y. et al, (2023), Cancer Med

The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study.

Bonet C. et al, (2023), Eur J Epidemiol

Associations between food group intakes and circulating insulin-like growth factor-I in the UK Biobank: a cross-sectional analysis.

Watling CZ. et al, (2023), Eur J Nutr, 62, 115 - 124

Load More